Shop By
Catalog No.
Product Name
Application
Product Information
Citations
-
transcriptional inhibitor of G0/G1 switch 2
NS-3-008 hydrochloride is an orally active transcriptional inhibitor of G0/G1 switch 2 (G0s2) with an IC50 of 2.25 μM. NS-3-008 hydrochloride can be used for chronic kidney disease. -
Glyoxalase I inhibitor
Glyoxalase I inhibitor is a potent Glyoxalase I inhibitor, candidate for anticancer agents. -
FUBP1 inhibitor
FUBP1-CIN-1 is a potent FUSE binding protein 1 (FUBP1) inhibitor which interferes with the binding of FUBP1 to its single stranded target DNA FUSE sequence , with an IC50 value of 11.0 μM. -
Noradrenalin re-uptake inhibitor
Nisoxetine hydrochloride is a selective and potent inhibitor of norepinephrine transporter with little or no affinity for a range of other neurotransmitter receptors. Nisoxetine hydrochloride is an inhibitor of SLC6A2. -
PKR Inhibitor
PKR Inhibitor is an oxindole/imidazole derivative that binds the ATP-binding site of PKR and blocks autophosphorylation with an IC50 value of 186-210 nM.3 PKR Inhibitor protects human neuroblastoma cells against cell damage triggered by tunicamycin-mediated endoplasmic reticulum stress. -
ENT1 inhibitor
NBMPR is a nucleoside analog that competitively inhibits the equilibrative nucleoside transporter 1 (Kd = 0.1-1.0 nM, IC50s = 4.6 and 3.6 nM in rat and human, respectively). -
DCPS inhibitor
RG3039 (PF-06687859) is orally bioavailable, brain-penetrant small molecule that has been shown to be an inhibitor of the mRNA decapping enzyme, DcpS. -
Alpha-galactosidase inhibitor
Deoxygalactonojirimycin Hydrochloride is a potent and selective Alpha-gal A (Alpha-galactosidase) inhibitor. -
OSC Inhibitor
Ro 48-8071 is an inhibitor of OSC(Oxidosqualene cyclase; IC50=6.5 nM) that has low-density lipoprotein (LDL) cholesterol lowering activity. -
NQO1 inhibitor
Dicoumarol is a competitive NADH quinone oxidoreductase (NQO1) inhibitor. -
cholinephosphotransferase inhibitor
Meclofenoxate HCl is an anti-aging drug used to treat the symptoms of senile dementia and Alzheimer's disease, and also inhibits the activity of cholinephosphotransferase. -
MPI inhibitor
MLS0315771 is a potent competitive phosphomannose isomerase (MPI) inhibitor. -
PEPCK inhibitor
SKF-34288 hydrochloride (3-Mercaptopicolinic acid) is a phosphoenolpyruvate carboxykinase (PEPCK) inhibitor. SKF-34288 hydrochloride is a potent hypoglycemic agent via inhibition of glucose synthesis through the specific inhibition of PEPCK in the gluconeogenesis pathway. -
FER tyrosine kinase inhibitor
DS21360717 is a potent and orally active FER tyrosine kinase inhibitor, with an IC50 of 0.49 nM. Anti-cancer activity. -
polyamine synthesis inhibitor
Sardomozide is a second-generation polyamine synthesis inhibitor, which inhibits the activity of the polyamine biosynthetic enzyme S-adenosylmethionine decarboxylase (SAMDC). -
PPCE inhibitor
Y-29794 Tosylate is an orally active, potent and specific non-peptide prolyl endopeptidase (PPCE) inhibitor. -
Prolyl endopeptidase inhibitor
Y-29794 oxalate, inhibitor of prolyl endopeptidase, is a serine peptidase that may be implicated in the biosynthesis of amyloid β-peptide. -
Proprotein convertases inhibitor
Decanoyl-RVKR-CMK is a selective, irreversible, and cell-permeable competitive inhibitor of proprotein convertases. -
furin inhibitor
Hexa-D-arginine is a inhibitor of furin (Ki values are 0.106, 0.58 and 13.2 uM for furin, PACE4 and PC1 respectively). -
SSAO/VAP-1 inhibitor
PXS-4728A is a very potent and highly selective compound in development for the treatment of cardiometabolic diseases like the liver-related disease Nonalcoholic Steatohepatitis (NASH).
